Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to $2.0 million.

  • Usana Health Sciences' Deferred Taxes rose 13226.18% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.2 million, marking a year-over-year decrease of 17769.59%. This contributed to the annual value of -$6.7 million for FY2024, which is 14532.56% down from last year.
  • Usana Health Sciences' Deferred Taxes amounted to $2.0 million in Q3 2025, which was up 13226.18% from -$7.8 million recorded in Q2 2025.
  • In the past 5 years, Usana Health Sciences' Deferred Taxes ranged from a high of $3.7 million in Q2 2022 and a low of -$10.5 million during Q3 2022
  • Moreover, its 5-year median value for Deferred Taxes was $1.1 million (2022), whereas its average is -$971588.2.
  • In the last 5 years, Usana Health Sciences' Deferred Taxes soared by 15426.46% in 2023 and then tumbled by 28359.43% in 2024.
  • Quarter analysis of 5 years shows Usana Health Sciences' Deferred Taxes stood at $3.0 million in 2021, then tumbled by 61.89% to $1.1 million in 2022, then rose by 29.89% to $1.5 million in 2023, then tumbled by 283.59% to -$2.7 million in 2024, then skyrocketed by 175.01% to $2.0 million in 2025.
  • Its Deferred Taxes stands at $2.0 million for Q3 2025, versus -$7.8 million for Q2 2025 and $1.4 million for Q1 2025.